Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

HilleVax Q4 2023 GAAP EPS $(0.78) Beats $(0.83) Estimate

Author: Benzinga Newsdesk | March 20, 2024 04:16pm
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.83) by 6.02 percent.

Posted In: HLVX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist